NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) PT Raised to C$5.50 at BMO Capital Markets

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its target price raised by research analysts at BMO Capital Markets from C$5.25 to C$5.50 in a report issued on Thursday, BayStreet.CA reports. BMO Capital Markets’ target price points to a potential upside of 3.58% from the stock’s previous close.

A number of other analysts have also recently weighed in on the stock. CIBC lowered their target price on shares of NorthWest Health Prop Real Est Inv Trust from C$5.75 to C$5.50 in a research note on Thursday, August 15th. National Bankshares set a C$5.50 target price on shares of NorthWest Health Prop Real Est Inv Trust and gave the stock a “sector perform” rating in a research report on Wednesday, September 4th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, NorthWest Health Prop Real Est Inv Trust currently has an average rating of “Hold” and an average target price of C$5.70.

NorthWest Health Prop Real Est Inv Trust Stock Down 1.7 %

Shares of NWH.UN stock traded down C$0.09 on Thursday, hitting C$5.31. The company’s stock had a trading volume of 317,598 shares, compared to its average volume of 651,467. The company has a debt-to-equity ratio of 129.42, a current ratio of 0.25 and a quick ratio of 0.06. NorthWest Health Prop Real Est Inv Trust has a fifty-two week low of C$3.89 and a fifty-two week high of C$5.88. The firm’s fifty day moving average price is C$5.23 and its 200-day moving average price is C$5.04. The stock has a market capitalization of C$1.31 billion, a price-to-earnings ratio of -3.35, a P/E/G ratio of 0.74 and a beta of 1.05.

About NorthWest Health Prop Real Est Inv Trust

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at June 30, 2020, the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 189 income-producing properties and 15.3 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.